SCHEMBL3626408

SCHEMBL3626408

CCCCC/C=C\C/C=C\CCCCCCC(C)(C)C(=O)O

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACLY P53396 1/20 0.77
ALDH1A1 P00352 5/20 0.60
PPARG P37231 5/20 0.60
F7 P08709 4/20 0.60
F3 P13726 4/20 0.60
PPARD Q03181 4/20 0.60
PPARA Q07869 4/20 0.60
KDM4E B2RXH2 4/20 0.60
FFAR1 O14842 3/20 0.60
LMNA P02545 2/20 0.60
CYP3A4 P08684 2/20 0.60
CYP19A1 P11511 2/20 0.60
FABP4 P15090 2/20 0.60
HPGD P15428 2/20 0.60
ALOX15 P16050 2/20 0.60
PTGS1 P23219 2/20 0.60
AKR1C3 P42330 2/20 0.60
NR4A2 P43354 2/20 0.60
HSD17B10 Q99714 2/20 0.60
TDP1 Q9NUW8 2/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3617659 1.00 ACLY (0.77) ACLYALDH1A1PPARGF7F3
SCHEMBL11863724 1.00 ACLY (0.77) ACLYALDH1A1PPARGF7F3
SCHEMBL13735034 1.00 ACLY (0.77) ACLYALDH1A1PPARGF7F3
SCHEMBL6237605 0.95 ACLY (0.85) ACLYPPARGF7F3PPARD
SCHEMBL3628647 0.95 ACLY (0.85) ACLYPPARGF7F3PPARD
SCHEMBL28101613 0.95 ACLY (0.85) ACLYPPARGF7F3PPARD
SCHEMBL1340693 0.95 ACLY (0.85) ACLYPPARGF7F3PPARD
SCHEMBL3628649 0.95 ACLY (0.85) ACLYPPARGF7F3PPARD
SCHEMBL1340692 0.95 ACLY (0.85) ACLYPPARGF7F3PPARD
SCHEMBL6498499 0.95 ACLY (0.85) ACLYPPARGF7F3PPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12479812-B2 Fatty acid derivatives and their use THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2025-11-25 US disclosed
US-11555021-B2 Fatty acid derivatives and their use THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2023-01-17 US disclosed
US-20220274940-A1 FATTY ACID DERIVATIVES AND THEIR USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN (US) 2022-09-01 US disclosed
US-20210139440-A1 FATTY ACID DERIVATIVES AND THEIR USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVIC (US) 2021-05-13 US disclosed
EP-3649115-A1 FATTY ACID DERIVATIVES AND THEIR USE The U.S.A. as represented by the Secretary, Department of Health and Human Services (US) 2020-05-13 EP disclosed
CN-110869354-A Fatty acid derivatives and uses thereof 美国政府(由卫生和人类服务部的部长所代表) 2020-03-06 CN disclosed
CN-110225742-A transparent solid cosmetic 高级醇工业株式会社 2019-09-10 CN disclosed
WO-2019010414-A1 FATTY ACID DERIVATIVES AND THEIR USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES (US) 2019-01-10 WO disclosed
US-7789934-B2 Combination of an N-alkyl- or N,N-dialkylpolyhydroxyalkanamide and a metal soap, an alkylenebisfatty amide, or an N-alkylalkanamide; improves both flowability and lubricity, regardless of a presence or absence of a complicated pretreatment step. KABUSHIKI KAISHA KOBE SEIKO SHO (JP) 2010-09-07 US disclosed
US-20070154340-A1 Lubricant for powder metallurgy, powdery mixture for powder metallurgy, and process for producing sinter KABUSHIKI KAISHA KOBE SEIKO SHO (JP) 2007-07-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210139440-A1 FATTY ACID DERIVATIVES AND THEIR USE FFAR3, FFAR1, FFAR2 ACLY 2124/4885ALDH1A1 1962/4885PPARG 111/4885
US-20220274940-A1 FATTY ACID DERIVATIVES AND THEIR USE FFAR3, FFAR1, FFAR2 ACLY 2124/4885ALDH1A1 1962/4885PPARG 111/4885
US-12479812-B2 Fatty acid derivatives and their use FFAR3, FFAR1, FFAR2 ACLY 2124/4885ALDH1A1 1962/4885PPARG 111/4885
US-11555021-B2 Fatty acid derivatives and their use FFAR3, FFAR1, FFAR2 ACLY 2124/4885ALDH1A1 1962/4885PPARG 111/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.